NLRC5 and melanoma: As the loss of MHC-I expression is a common immune escape mechanism in cancers and NLRC5 is the key transcriptional activator of MHC-I genes, our laboratory studied the impact of NLRC5 on antitumor immunity using the B16.F10 murine melanoma model [29].